168 related articles for article (PubMed ID: 17406612)
1. In vitro screening for molecules that affect virus capsid assembly (and other protein association reactions).
Zlotnick A; Lee A; Bourne CR; Johnson JM; Domanico PL; Stray SJ
Nat Protoc; 2007; 2(3):490-8. PubMed ID: 17406612
[TBL] [Abstract][Full Text] [Related]
2. An in vitro fluorescence screen to identify antivirals that disrupt hepatitis B virus capsid assembly.
Stray SJ; Johnson JM; Kopek BG; Zlotnick A
Nat Biotechnol; 2006 Mar; 24(3):358-62. PubMed ID: 16474383
[TBL] [Abstract][Full Text] [Related]
3. A mutant hepatitis B virus core protein mimics inhibitors of icosahedral capsid self-assembly.
Bourne CR; Katen SP; Fulz MR; Packianathan C; Zlotnick A
Biochemistry; 2009 Mar; 48(8):1736-42. PubMed ID: 19196007
[TBL] [Abstract][Full Text] [Related]
4. BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly.
Stray SJ; Zlotnick A
J Mol Recognit; 2006; 19(6):542-8. PubMed ID: 17006877
[TBL] [Abstract][Full Text] [Related]
5. Assembly Properties of Hepatitis B Virus Core Protein Mutants Correlate with Their Resistance to Assembly-Directed Antivirals.
Ruan L; Hadden JA; Zlotnick A
J Virol; 2018 Oct; 92(20):. PubMed ID: 30089690
[TBL] [Abstract][Full Text] [Related]
6. Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1.
Bourne CR; Finn MG; Zlotnick A
J Virol; 2006 Nov; 80(22):11055-61. PubMed ID: 16943288
[TBL] [Abstract][Full Text] [Related]
7. Antivirals interacting with hepatitis B virus core protein and core mutations may misdirect capsid assembly in a similar fashion.
Hacker HJ; Deres K; Mildenberger M; Schröder CH
Biochem Pharmacol; 2003 Dec; 66(12):2273-9. PubMed ID: 14637185
[TBL] [Abstract][Full Text] [Related]
8. Evolution of Intermediates during Capsid Assembly of Hepatitis B Virus with Phenylpropenamide-Based Antivirals.
Kondylis P; Schlicksup CJ; Katen SP; Lee LS; Zlotnick A; Jacobson SC
ACS Infect Dis; 2019 May; 5(5):769-777. PubMed ID: 30616343
[TBL] [Abstract][Full Text] [Related]
9. Modulators of HBV capsid assembly as an approach to treating hepatitis B virus infection.
Cole AG
Curr Opin Pharmacol; 2016 Oct; 30():131-137. PubMed ID: 27636324
[TBL] [Abstract][Full Text] [Related]
10. A small molecule inhibits and misdirects assembly of hepatitis B virus capsids.
Zlotnick A; Ceres P; Singh S; Johnson JM
J Virol; 2002 May; 76(10):4848-54. PubMed ID: 11967301
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design and biochemical evaluation of sulfanilamide derivatives as hepatitis B virus capsid assembly inhibitors.
Cho MH; Song JS; Kim HJ; Park SG; Jung G
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):916-25. PubMed ID: 22803663
[TBL] [Abstract][Full Text] [Related]
12. Competition between Normative and Drug-Induced Virus Self-Assembly Observed with Single-Particle Methods.
Kondylis P; Schlicksup CJ; Brunk NE; Zhou J; Zlotnick A; Jacobson SC
J Am Chem Soc; 2019 Jan; 141(3):1251-1260. PubMed ID: 30537810
[TBL] [Abstract][Full Text] [Related]
13. Calcium ions affect the hepatitis B virus core assembly.
Choi Y; Gyoo Park S; Yoo JH; Jung G
Virology; 2005 Feb; 332(1):454-63. PubMed ID: 15661175
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus core protein allosteric modulators can distort and disrupt intact capsids.
Schlicksup CJ; Wang JC; Francis S; Venkatakrishnan B; Turner WW; VanNieuwenhze M; Zlotnick A
Elife; 2018 Jan; 7():. PubMed ID: 29377794
[TBL] [Abstract][Full Text] [Related]
15. A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly.
Stray SJ; Bourne CR; Punna S; Lewis WG; Finn MG; Zlotnick A
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8138-43. PubMed ID: 15928089
[TBL] [Abstract][Full Text] [Related]
16. Novel non-HAP class A HBV capsid assembly modulators have distinct
Vanrusselt H; Kum DB; Taverniti V; Liu C; Acosta Sanchez A; Corthout N; Munck S; Baumert TF; Beigelman L; Blatt LM; Symons JA; Deval J; Raboisson P; Verrier ER; Jekle A; Vendeville S; Debing Y
J Virol; 2023 Oct; 97(10):e0072223. PubMed ID: 37754761
[TBL] [Abstract][Full Text] [Related]
17. An Aptamer against the Matrix Binding Domain on the Hepatitis B Virus Capsid Impairs Virion Formation.
Orabi A; Bieringer M; Geerlof A; Bruss V
J Virol; 2015 Sep; 89(18):9281-7. PubMed ID: 26136564
[TBL] [Abstract][Full Text] [Related]
18. 2-amino-N-(2,6-dichloropyridin-3-yl)acetamide derivatives as a novel class of HBV capsid assembly inhibitor.
Cho MH; Jeong H; Kim YS; Kim JW; Jung G
J Viral Hepat; 2014 Dec; 21(12):843-52. PubMed ID: 24372792
[TBL] [Abstract][Full Text] [Related]
19. Discovery of New Hepatitis B Virus Capsid Assembly Modulators by an Optimal High-Throughput Cell-Based Assay.
Pei Y; Wang C; Ben H; Wang L; Ma Y; Ma Q; Xiang Y; Zhang L; Liu G
ACS Infect Dis; 2019 May; 5(5):778-787. PubMed ID: 30761887
[TBL] [Abstract][Full Text] [Related]
20. Novel non-heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro.
Corcuera A; Stolle K; Hillmer S; Seitz S; Lee JY; Bartenschlager R; Birkmann A; Urban A
Antiviral Res; 2018 Oct; 158():135-142. PubMed ID: 30031759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
